Biotechnology and Investment Seminar of George Church was held in Hangzhou on October 31. George Church, a pioneer of genomics, delivered a speech on the breakthrough of biotechnology at the seminar as the founder. Professor George Church thus began his trip in China.
Professor Church showed the new genomics platform, Nebula Genomics, which is an under development online platform that allows individuals, researchers and other data buyers to share their genome data on it. By using blockchain and cryptographic technology, Nebula ensures the security and privacy of personal data and controls how it is shared. Through this platform, individuals can provide their own data and be paid by researchers who access it, which will help reduce or even eliminate the cost of genomes sequencing of individuals.
"We believe that individuals should be rewarded for providing health data to researchers and pharmaceutical companies while maintaining full control over the privacy and security of their health data," says Church."Nebula Genomics addresses the critical issues of cost and privacy that are holding back widespread sequencing and adoption around the globe."
The Nebula platform provides researchers with end-to-end Genomics as a Service (GaaS) solution that provide large-scale genome and other health information for advanced research in genetic diseases and new drug development. Researchers will be able to find the most appropriate data as needed, compensate the individuals who provided it, and then analyze it on the Nebula platform.
"We're eliminating middlemen through our platform to make it faster, better, and easier for researchers to access and analyze health data," says Dennis Grishin, Chief Science Officer and Co-founder of Nebula Genomics. "Both individuals and researchers will be able to participate in the market through the data exchange system, which will accelerate research and improve health care outcomes."
By encouraging more people to understand their genes and share this valuable information with researchers, Nebula Genomics is building a platform that will help user in the era of personalized medicine.
About Nebula Genomics
Nebula Genomics is a human genome sequencing and health big data company whose mission is to create a large, trusted market for genome and health data for consumers, researchers and the medical community, ushering in the era of genome sequencing. The Nebula market, which uses blockchain to ensure that consumers maintain control of their data and are rewarded for the use of that data, will bring together significant and rich genetic information that researchers can analyze to accelerate drug development, streamline clinical trials and usher in the era of truly individualized medicine. The company's founders are George Church, a pioneer of Harvard genomics, and Harvard researchers Dennis Grishin and Kamal Obbad. Nebula Genomics was founded in 2017 with offices in San Francisco, California and Boston, Massachusetts and favored by investors of Khosla Ventures, Arch Venture Partners, Fenbushi Capital, Mayfield, F-Prime Capital Partners, Great Point Ventures, Windham Venture Partners, Hemi Ventures, Mirae Asset, Hikma Ventures and Heartbeat Labs. For further information, please follow @NebulaGenomics on Twitter and Facebook or visit nebula.org.